NCT05603533 Adherence by Music to Exercise in Dementia: Group Therapy
| NCT ID | NCT05603533 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hasselt University |
| Condition | Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2023-01-09 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2023-01-09 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to asses the effect of a music and video-based group exercise therapy on motivation, physical functioning, cognition and well-being in older adults with moderate dementia.
Eligibility Criteria
Inclusion Criteria: * Men and women with moderate dementia (MMSE between 12 and 20) * Age 65 years or older * Resident in nursing home for at least 30 days * Able to stand (supported) for 10 seconds with supervision Exclusion Criteria: * Inadequate functional hearing * Uncorrected visual problems * Rehabilitating from an orthopedic or neurologic insult * Known disability that significantly influences 6 month prognosis
Contact & Investigator
Joke Spildooren, Prof. dr.
STUDY DIRECTOR
Hasselt University
Frequently Asked Questions
Who can join the NCT05603533 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05603533 currently recruiting?
Yes, NCT05603533 is actively recruiting participants. Contact the research team at tine.plattiau@uhasselt.be for enrollment information.
Where is the NCT05603533 trial being conducted?
This trial is being conducted at Kasterlee, Belgium, Beverst, Belgium, Hasselt, Belgium, Opglabbeek, Belgium.
Who is sponsoring the NCT05603533 clinical trial?
NCT05603533 is sponsored by Hasselt University. The principal investigator is Joke Spildooren, Prof. dr. at Hasselt University. The trial plans to enroll 75 participants.